Candel Therapeutics (CADL) EBITDA Margin (QoQ) (2020 - 2022)
Candel Therapeutics (CADL) EBITDA Margin (QoQ) (2020 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Candel Therapeutics | 542.51 Mn | 542.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 251,613.00 |
| Sep 30, 2022 | -41,290.00 |
| Jun 30, 2022 | 75,161.00 |
| Mar 31, 2022 | 10.00 Mn |
| Dec 31, 2021 | -10.31 Mn |
| Sep 30, 2021 | -880,000.00 |
| Jun 30, 2021 | -207,742.00 |
| Mar 31, 2021 | 473,548.00 |
| Dec 31, 2020 | -1.09 Mn |
| Sep 30, 2020 | -41,935.00 |